Shivalik Rasayan Limited
SHIVALIK.NS
₹290.00
▲ 2.75%
Shivalik Rasayan shares gained 2.75% to close at ₹290 after the company received a Certificate of Suitability for Pirfenidone from the European Directorate for Quality of Medicine & Healthcare, a regulatory nod that has historically triggered sharp rallies in this counter. Despite today's bounce, the small-cap API and agrochemical maker remains deep in negative territory, down nearly 37% over the past six months and almost 60% over the last year, with the stock trading well below its 52-week high of ₹651 and closer to its low of ₹206.4. No brokerage target has been flagged for this move, underscoring the high-volatility, news-driven nature of this counter, and longer-term CAGR figures — down over 22% annually across the 5 and 10-year windows — point to a stock that has struggled to hold on to its rally-driven gains in the past.
CAGR Performance
| 1 Year | 2 Years | 5 Years | 10 Years |
|---|---|---|---|
| -37.80% | -28.00% | -22.09% | -22.09% |
Related News
No comments:
Post a Comment